Scott Lingle, the co-founder of fast-growing Remodel Health, took a big leap at an age when most folks are getting more conservative. Now he’s helping hundreds of local high schoolers learn to launch businesses.
Read More
The Riley Children’s Foundation unveiled the campaign, called “Every Child Deserves Riley,” during its Red For Our Kids Gala on Saturday. The effort has seen early success—they’ve already quietly raised two-thirds of the goal.
Read More
It’s been another busy year in Indiana health care and life sciences, with headlines nearly every week announcing another billion-dollar deal or investment.
Read More
In the survey from NORC at the University of Chicago, about 8 in 10 U.S. adults said the person who committed the killing has “a great deal” or “a moderate amount” of responsibility.
Read More
The Danish pharmaceutical company, which competes heavily with Indianapolis-based Eli Lilly and Co. in the weight-loss market, is leaving by “mutual agreement” with the company’s board of directors.
The once-endangered 95-year-old building, which was moved to its current location in 1995, has been mostly vacant since the closure of Dunaway’s restaurant in late 2014.
Diversity, equity and inclusion, or DEI, efforts have become a debated topic in the corporate world and beyond this year.
Experts say more research needs to be done to understand what drove the reduction, but they mention several possible factors.
The Zimmer Biomet Oxford Cementless Partial Knee System received FDA approval in November, although the implant has been used in more than 300,000 procedures outside the U.S.
The nation’s largest health insurer suspended its full-year financial outlook due to higher-than-expected medical costs.
The Swiss pharmaceutical and diagnostics giant said the move will establish the Indianapolis-based Roche Diagnostics site as a hub for manufacturing of its continuous glucose monitoring system.
The sweeping executive order sets a deadline for drugmakers to lower the cost of prescription drugs in the United States or face new limits over what the government will pay.
The proposal, expected to be announced by President Trump on Monday, will face fierce opposition from the pharmaceutical industry.
The company has announced more than $50 billion in new U.S. manufacturing investments since 2020.
Chief Scientific Officer Dr. Daniel Skovronsky talked with the IBJ about his hopes for the Lilly Medicine Foundry, which the Indianapolis-based drugmaker broke ground on this week.
House Bill 1004’s core pricing scrutiny targets hospital systems with $2 billion or more in net patient service revenue in the state.
Greenfield-based Elanco Health on Monday announced the $295 million cash sale of future U.S. royalty and milestone rights for the human use of a medication typically used for dogs and cats.
Carmel-based Forté Sports Medicine and Orthopedics now has 26 physicians and five offices in the Indianapolis area,
CVS Health’s pharmacy benefits manager said weight-loss drugs from rival drugmaker Novo Nordisk will become the preferred options on its standard formulary, or list of covered drugs, as of July 1.
The Indianapolis-based drugmaker also reaffirmed its 2025 revenue guidance but noted that the calculation was based on existing tariff and trade policies.
The desire to preserve a girl’s flowing hair during brain surgery led to the development of a comb-like device that could help cranial surgery patients avoid having their heads shaved.
The legislation threatens to strip the state’s largest hospital systems of their nonprofit status if their prices exceed state average prices.
The analysis—conducted and presented by Butler University students—was the winning entry into the recent Total Cost of Care Data Challenge contest.
It would be a sweeping change for U.S. food producers, who would likely replace the dyes with natural substitutes.
